ezetimibe has been researched along with cephalexin in 2 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (cephalexin) | Trials (cephalexin) | Recent Studies (post-2010) (cephalexin) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 2,229 | 338 | 329 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Corsiero, D; Girbig, F; Glombik, H; Heuer, H; Kramer, W; Petry, S; Schäfer, H; Wendler, W; Weyland, C | 1 |
1 review(s) available for ezetimibe and cephalexin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ezetimibe and cephalexin
| Article | Year |
|---|---|
Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter.
Topics: Animals; Anticholesteremic Agents; Azetidines; Bile Acids and Salts; Carrier Proteins; Cephalexin; Cholesterol; Drug Design; Ezetimibe; Fatty Acids; Glucose; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Microvilli; Rabbits; Structure-Activity Relationship | 2000 |